Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice.

PloS one | 2010

In the last decades, few mechanistically novel therapeutic agents have been developed to treat mental and neurodegenerative disorders. Numerous studies suggest that targeting BDNF and its TrkB receptor could be a promising therapeutic strategy for the treatment of brain disorders. However, the development of potent small ligands for the TrkB receptor has proven to be difficult. By using a peptidomimetic approach, we developed a highly potent and selective TrkB inhibitor, cyclotraxin-B, capable of altering TrkB-dependent molecular and physiological processes such as synaptic plasticity, neuronal differentiation and BDNF-induced neurotoxicity. Cyclotraxin-B allosterically alters the conformation of TrkB, which leads to the inhibition of both BDNF-dependent and -independent (basal) activities. Finally, systemic administration of cyclotraxin-B to mice results in TrkB inhibition in the brain with specific anxiolytic-like behavioral effects and no antidepressant-like activity. This study demonstrates that cyclotraxin-B might not only be a powerful tool to investigate the role of BDNF and TrkB in physiology and pathology, but also represents a lead compound for the development of new therapeutic strategies to treat brain disorders.

Pubmed ID: 20333308 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIMH NIH HHS, United States
    Id: K08 MH079088-03
  • Agency: NIMH NIH HHS, United States
    Id: K08 MH079088-03S1
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH091844-02
  • Agency: NIMH NIH HHS, United States
    Id: K08 MH079088-02
  • Agency: NIMH NIH HHS, United States
    Id: K08 MH079088-05
  • Agency: NIMH NIH HHS, United States
    Id: K08 MH079088-04
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH091844-01
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH091844
  • Agency: NIMH NIH HHS, United States
    Id: K08 MH079088
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH091844-03
  • Agency: NIMH NIH HHS, United States
    Id: K08 MH079088-01

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BioWorks (tool)

RRID:SCR_014594

A a configurable software package for peptide and protein mass spectrometry analyses. It includes the SEQUEST search algorithm to identify separate proteins in complex mixtures, interactive navigation tools to filter and sort protein summaries, customized spectral plots, and chromatograms using the PEPMATCH and PEPMAP tools. This software also has batch processing capabilities to improve throughput by queuing up several files, and custom-build proprietary databases, index databases, and retrieve databases through a public server.

View all literature mentions

PC12 (tool)

RRID:CVCL_0481

Cell line PC12 is a Cancer cell line with a species of origin Rattus norvegicus

View all literature mentions

SD (tool)

RRID:RGD_70508

Rattus norvegicus with name SD from RGD.

View all literature mentions

Swiss nude (tool)

RRID:MGI:5649767

laboratory mouse with name Swiss nude from MGI.

View all literature mentions

B6.Cg-Tg(Camk2a-cre)T29-1Stl/J (tool)

RRID:IMSR_JAX:005359

Mus musculus with name B6.Cg-Tg(Camk2a-cre)T29-1Stl/J from IMSR.

View all literature mentions